$INBX
Inhibrx Biosciences, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$109.35
▲+4.41%+$4.62
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateInhibrx Biosciences, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is INBX up today? It is at $109.35 (+4.41%), and our scanner flagged it 94 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment INBX spikes, and full due diligence on INBX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $INBX 94 times in the last 30 days. Create a free account to track $INBX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on INBX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for INBX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Kayyem Jon Faiz Director | Bought (open market) | +5K 0.03% of company | added 0.5% | 1.07M | $500K at $100.00 | Sep 16, 26 |
Manhard Kimberly Director | Sold (automatic/other) | -500 | sold 6.3% | 8K | $53K at $105.05 | Sep 15, 26 |
Manhard Kimberly Director | Sold (automatic/other) | -500 | sold 5.9% | 8K | $55K at $110.26 | Sep 14, 26 |
Manhard Kimberly Director | Sold (automatic/other) | -500 | sold 5.6% | 9K | $56K at $111.78 | Sep 11, 26 |
Manhard Kimberly Director | Sold (automatic/other) | -500 | sold 5.3% | 9K | $58K at $115.80 | Sep 9, 26 |
Lappe Mark Officer | Bought (open market) | +25K 0.2% of company | added 2.7% | 950K | $2.5M at $99.29 | Sep 8, 26 |
Forsyth Douglas Director | Bought (open market) | +3K 0.02% of company | added 1.1% | 227K | $287K at $114.65 | Sep 8, 26 |
Kayyem Jon Faiz Director | Bought (open market) | +5K 0.03% of company | added 0.5% | 1.06M | $568K at $113.52 | Sep 8, 26 |
Manhard Kimberly Director | Sold (automatic/other) | -500 | sold 5.0% | 10K | $58K at $115.14 | Sep 8, 26 |
Viking Global Investors Lp Beneficial Owner (10%) | Sold (automatic/other) | -350K 2.4% of company | sold 20% | 1.44M | $11.3M at $32.25 | Oct 7, 25 |
Kayyem Jon Faiz Director | Sold (automatic/other) | -90K 0.6% of company | sold 7.8% | 1.06M | n/a | Mar 27, 25 |
Kayyem Jon Faiz Director | Sold (automatic/other) | -500K 3.4% of company | sold 50% | 509K | n/a | Dec 16, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on INBX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for INBX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
INBX last traded at $109.35, up 4.41% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The INBX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged INBX 94 times in the last 30 days.
INBX (Inhibrx Biosciences, Inc. Common Stock) trades on XNAS, with a market cap of about $1.61B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge INBX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$INBX discussion
Sign in to ask a question or join the discussion.